Riskpilot← Back to searchSign inGet full accessSKANSENKLINIKKEN AS
ASActiveOrg 917530254Koldalsvegen 2C, 4700 VenneslaPhysiotherapy activities · NACE 8695Est. 20160 employees
Revenue 2025
NOK 2,2M
+26% vs 2024
EBITDA margin
30.5%
+637% vs 2024
Equity ratio
27.6%
Financial strength
Net profit 2025
NOK 242K
+225% vs 2024
| Revenue | NOK 2,2M | +26% |
| EBITDA | NOK 676K | +637% |
| Net profit | NOK 242K | +225% |
| Total assets | NOK 2,5M | -5% |
| Equity | NOK 694K | +54% |
| Employees | 0 | — |
Legal name
SKANSENKLINIKKEN AS
Org number
917530254
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
30. august 2016
Share capital
NOK 240 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drive fysikalsk og kiropraktisk behandling, trening, habilitering, medvirke i andre selskaper i samme virksomhet, utleie av behandlingsrom/praksisplass, samt alt som hører naturlig til dette.
Address
Koldalsvegen 2C, 4700 Vennesla
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 497 | 1 589 | 1 712 | 1 762 | 2 218 |
| Staff expenses | −0 | −0 | −0 | −11 | −0 |
| EBITDA | 358 | 256 | 438 | 92 | 676 |
| Depreciation & amort. | −140 | −188 | −191 | −205 | −246 |
| EBIT | 218 | 68 | 248 | −113 | 430 |
| Net financials | −51 | −96 | −132 | −136 | −120 |
| Profit before tax | 168 | −28 | 115 | −249 | 311 |
| Tax | 37 | −6 | 25 | −55 | 68 |
| Net profit | 131 | −22 | 90 | −194 | 242 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 818 | 2 651 | 2 664 | 2 644 | 2 513 |
| Equity | 483 | 461 | 551 | 452 | 694 |
| Long-term debt | 2 274 | 2 122 | 1 970 | 1 818 | 0 |
| Short-term debt | 61 | 68 | 143 | 374 | 153 |
| Total debt | 2 335 | 2 190 | 2 113 | 2 192 | 1 819 |
EBITDA margin
30.5%
This company
15.8%
Market median
+93% vs market
20212025
Equity ratio
27.6%
This company
38.2%
Market median
-28% vs market
20212025
Return on equity
34.9%
This company
18.4%
Market median
+90% vs market
20212025
Net profit margin
10.9%
This company
8.1%
Market median
+35% vs market
20212025
Asset turnover
0.88×
This company
1.12×
Market median
+21% vs market
20212025
Debt / equity
2.62×
This company
0.62×
Market median
-323% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 14.29% | 14.29% | 2022 | |
| Individual | 14.29% | 14.29% | 2022 | |
| Individual | 14.29% | 14.29% | 2022 | |
| Company | 14.29% | 14.29% | 2022 | |
| Individual | 14.29% | 14.29% | 2022 | |
| Company | 14.29% | 14.29% | 2022 | |
| Company | 14.29% | 14.29% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SKANSENKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sandra Iversen Gautestad | Board of Directors | 0 companies |
| Toralf Westermoen | Chairman | 0 companies |
| Pål Aksel Hagerup Andresen | Board of Directors | 0 companies |
| Janne Kathrine Grønheden Prosgaard | Board of Directors | 0 companies |